We are live on ! Find out more
PFE icon

Pfizer
PFE

2,910 hedge funds and large institutions have $109B invested in Pfizer in 2024 Q3 according to their latest regulatory filings, with 191 funds opening new positions, 1,243 increasing their positions, 1,199 reducing their positions, and 124 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more first-time investments, than exits

New positions opened: 191 | Existing positions closed: 124

27% more funds holding in top 10

Funds holding in top 10: 33 → 42 (+9)

1% more funds holding

Funds holding: 2,874 → 2,910 (+36)

4% more repeat investments, than reductions

Existing positions increased: 1,243 | Existing positions reduced: 1,199

4% more capital invested

Capital invested by funds: $105B → $109B (+$3.84B)

0.39% more ownership

Funds ownership: 66.08% → 66.47% (+0.39%)

38% less call options, than puts

Call options by funds: $2.51B | Put options by funds: $4.05B

Holders
2,910
Holders Change
+36
Holders Change %
+1.25%
% of All Funds
41.78%
Holding in Top 10
42
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+27.27%
% of All Funds
0.6%
New
191
Increased
1,243
Reduced
1,199
Closed
124
Calls
$2.51B
Puts
$4.05B
Net Calls
-$1.54B
Net Calls Change
-$268K

Top Buyers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$425M
2
Charles Schwab
Charles Schwab
California
+$375M
3
Barclays
Barclays
United Kingdom
+$345M
4
BlackRock
BlackRock
New York
+$339M
5
Deutsche Bank
Deutsche Bank
Germany
+$286M

Top Sellers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
-$1.01B
2
Citadel Advisors
Citadel Advisors
Florida
-$360M
3
Goldman Sachs
Goldman Sachs
New York
-$265M
4
Franklin Resources
Franklin Resources
California
-$262M
5
DCP
D1 Capital Partners
New York
-$213M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$673M +$96M +3,292,353 +17%
Wells Fargo
27
Wells Fargo
California
$607M -$8.83M -302,785 -1%
T. Rowe Price Associates
28
T. Rowe Price Associates
Maryland
$606M +$113M +3,865,041 +23%
Ameriprise
29
Ameriprise
Minnesota
$584M +$55.7M +1,909,118 +10%
HSBC Holdings
30
HSBC Holdings
United Kingdom
$520M -$10.7M -365,553 -2%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$491M -$23.6M -809,100 -5%
Swiss National Bank
32
Swiss National Bank
Switzerland
$487M +$2.94M +100,900 +0.6%
Diamond Hill Capital Management
33
Diamond Hill Capital Management
Ohio
$479M +$19.2M +658,420 +4%
VanEck Associates
34
VanEck Associates
New York
$478M +$13.3M +456,168 +3%
Franklin Resources
35
Franklin Resources
California
$478M -$262M -8,973,684 -35%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$466M -$10M -343,256 -2%
N
37
Nuveen
North Carolina
$457M -$77.6M -2,659,550 -14%
Millennium Management
38
Millennium Management
New York
$448M -$130M -4,448,515 -22%
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$447M +$8.39M +287,512 +2%
Federated Hermes
40
Federated Hermes
Pennsylvania
$434M +$2.04M +70,072 +0.5%
Marshall Wace
41
Marshall Wace
United Kingdom
$426M +$273M +9,352,034 +174%
Fidelity Investments
42
Fidelity Investments
Massachusetts
$419M +$12.7M +435,311 +3%
Neuberger Berman Group
43
Neuberger Berman Group
New York
$404M +$4.36M +149,492 +1%
Sumitomo Mitsui Trust Group
44
Sumitomo Mitsui Trust Group
Japan
$380M +$15.9M +544,418 +4%
LSV Asset Management
45
LSV Asset Management
Illinois
$375M +$34.8M +1,193,527 +10%
UE
46
Unisphere Establishment
Liechtenstein
$366M – – –
First Trust Advisors
47
First Trust Advisors
Illinois
$346M -$187K -6,418 -0.1%
National Pension Service
48
National Pension Service
South Korea
$333M +$51.4M +1,762,520 +18%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$298M +$35.7M +1,223,710 +13%
LPL Financial
50
LPL Financial
California
$289M +$22.7M +777,478 +8%
1
2
3 4 5

PFE Hedge Fund Activity: Q3 2024 in Review

2,910 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q3 2024, worth a combined $109B — up 3.7% from $105B a quarter earlier.

Buyers outnumbered sellers: 191 funds opened new PFE positions and 124 closed out — a net gain of 67 holders — while 1,243 added to existing stakes and 1,199 trimmed.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $425M. The largest seller was Capital World Investors, cutting an estimated $1.01B.

  • 2,910 institutional investors held Pfizer (PFE) as of Q3 2024, up from 2,874 in Q2 2024.
  • Funds reported $109B of Pfizer stock for Q3 2024, up 3.7% quarter-over-quarter.
  • 191 funds opened new Pfizer positions in Q3 2024 and 124 closed out, a net change of +67 holders.
  • The largest Pfizer buyer in Q3 2024 was BNP Paribas Financial Markets, an estimated $425M added.
  • The largest Pfizer seller in Q3 2024 was Capital World Investors, an estimated $1.01B sold.

Based on aggregated 13F filings for Q3 2024.